Table 1.
Eradication rate after one- or two-staged revision in THA and TKA.
| Author |
Year |
Patients [n] |
Follow-up [years] |
Eradication rate [% ± SD] |
|---|---|---|---|---|
| TKA, one-staged revision | ||||
| Silva et al.22 | 2002 | 37 | 4 | 89 |
| Buechel et al.23 | 2004 | 22 | 10.2 | 91 |
| Bauer et al.24 | 2006 | 30 | 4.5 | 67 |
| Singer et al.25 | 2012 | 63 | 2 | 95 |
| Jenny et al.26 | 2013 | 47 | 3 | 87 |
| Tibrewal et al.27 | 2014 | 50 | 10.5 | 92 |
| Zahar et al.28 | 2015 | 70 | 9 | 93 |
| Haddad et al.8 | 2015 | 28 | 6.5 | 100 |
| Jenny et al.9 | 2016 | 130 | 3.2 | 81 |
| Massin et al.29 | 2016 | 108 | 3.5 | 77 |
| Siddiqi et al.10 | 2018 | 57 | 4.3 | 86 |
|
Total |
642 |
μ = 5.5 |
87 ± 8.8* |
|
| TKA, two-staged revision | ||||
| Fehring et al.30 | 2000 | 55 | 3 | 90 |
| Emerson et al.31 | 2002 | 48 | 5.6 | 92 |
| Meek et al.32 | 2003 | 48 | 3.3 | 96 |
| Haleem et al.33 | 2004 | 96 | 7.2 | 91 |
| Durbhakula et al.34 | 2004 | 24 | 2.8 | 92 |
| Cuckler et al.35 | 2005 | 44 | 5.4 | 98 |
| Hofmann et al.36 | 2005 | 50 | 6 | 88 |
| Huang et al.37 | 2006 | 21 | 4.5 | 97 |
| Jämsen et al.38 | 2006 | 34 | 2.8 | 85 |
| Bauer et al.24 | 2006 | 77 | 4.5 | 67 |
| Hsu et al.39 | 2007 | 28 | 2 | 87 |
| Ghanem et al.40 | 2009 | 109 | 2.8 | 79 |
| Westrich et al.41 | 2010 | 75 | 4.4 | 73 |
| Mortazavi et al.5 | 2011 | 117 | 3.8 | 72 |
| Choi et al.42 | 2012 | 47 | 3.6 | 68 |
| Sabry et al.43 | 2014 | 291 | 3.3 | 72 |
| Haddad et al.8 | 2015 | 74 | 6.5 | 93 |
| Lichstein et al.44 | 2016 | 121 | 3.7 | 94 |
| Massin et al.29 | 2016 | 177 | 4.6 | 69 |
| Ford et al.45 | 2018 | 56 | 3.3 | 54 |
| Petis et al.46 | 2019 | 245 | 14 | 83 |
| Siddiqi et al.10 | 2018 | 137 | 4.6 | 76 |
| Total | 1148 | μ = 4.6 | 83 ± 11.7 * | |
*p = 0.385.